Submit Deal

Announced

3 Mar 2025

Completed

3 Mar 2025

Revvity completed the acquisition of the AI R&D platform of Spring Science.

Synopsis

Revvity, a life sciences and diagnostics company, completed the acquisition of the AI R&D platform of Spring Science, a biotechnology company. Financial terms were not disclosed.

Principals

target

Spring (ai R&d Platform)

bidder

Revvity

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

Sort

Bidder Team (2)

prahlad singh

President and CEO at REVVITY INC

Manager

bidder

Deals

£ 6.82 B

Total Value

max krakowiak

Senior Vice President and Chief Financial Officer at REVVITY INC

Manager

bidder

Deal

n/a

Total Value

Vendor Team (4)

tom babich

‎Managing Director at Stifel

Financial Advisor

vendor

Deals

£ 239 M

Total Value

tim opler

Managing Director at Stifel

Financial Advisor

vendor

Deals

£ 516 M

Total Value

shane moriarty

Associate at Stifel

Financial Advisor

vendor

Deals

n/a

Total Value

ben kamens

Founder and CEO at SPRING SCIENCE INC

Manager

vendor

Deal

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy